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Polystyrene resins are widely used for food
packaging, such as take-out food containers,
coffee cups, meat trays, soup bowls, and salad
boxes. From these containers, styrene
oligomers sometimes migrate into the food
(Sakamoto et al. 2000). With the polystyrene-
container–packed instant foods such as 
noodles and rice, migration from the cups
into these foods after cooking resulted in
0–8.1 µg/cup of 2,4,6-triphenyl-1-hexene
(ST-1), 0–13.8 µg/cup of 1a-phenyl-4a-(1´-
phenylethyl) tetralin (ST-2) and 1a-phenyl-4e-
(1´-phenylethyl) tetralin (ST-3), 0–5.3 µg/cup
of 1-e-phenyl-4a-(1´-phenylethyl) tetralin
(ST-4), and 0–8.4 µg/cup of 1-e-phenyl-4e-
(1´-phenylethyl) tetralin (ST-5) (Kawamura
et al. 1998). When instant noodles or soups in
the polystyrene cups were cooked according to
the manufacturer’s instructions, 0.8–21 ng/g
ST-1, 1.1–16 ng/g ST-2, 1.2–19 ng/g ST-3,
0.6–8.6 ng/g ST-4, 0.4–8.6 ng/g ST-5,
0.4–5.1 ng/g 1e,3e,5e-triphenylcyclohexane
(ST-7), and 0.3–1.3 ng/g structurally uncer-
tain isomer (ST-8) migrated into the food
(Kaneko et al. 2003). Some polystyrene instant
noodle containers themselves contained
80–980 µg/g ST-1, 10–980 µg/g ST-2,
20–970 µg/g ST-3, 190–650 µg/g ST-4,
210–670 µg/g ST-5, 10–40 µg/g 1e,3e,5a-
triphenylcyclohexane (ST-6), 80–280 µg/g
ST-7, and 40–90 µg/g ST-8 (Kaneko et al.
2003). However, the contents of styrene
trimers (STs) in these polystyrene containers
were clearly lower than those reported by
Sakamoto et al. (2001), suggesting that the
quality of polystyrene food containers is
improving.
Although people are often potentially
exposed to STs, there are some conflicting
ﬁndings about their toxicity. A binding assay
for several receptors showed that synthesized
STs [ST-1, ST-3, and 1-phenyl-4-(2-phenyl-
ethyl) tetralin (ST-12)] did not bind to estro-
gen receptors (ERs), androgen receptors, and
thyroid hormone receptors of uterus, ventral
prostate, and liver from Sprague-Dawley rats
(Date et al. 2002; Ohno et al. 2002a, 2002b).
Similarly, at 10–5 M, these compounds did
not accelerate the proliferation of MCF-7
human breast cancer cells, suggesting that they
do not have potentially adverse effects similar
to those of estrogen (Nobuhara et al. 1999;
Ohno et al. 2002a). In addition, oral adminis-
tration of oligomers extracted from general-
purpose, high-impact, and expandable
polystyrene materials did not influence the
uterine weight in Wistar rats (Bachmann et al.
1998). Three STs (ST-1, ST-3, and ST-12)
from noodle containers did not inﬂuence the
uterine weight or serum prolactin concentra-
tion in of Sprague-Dawley rats (Date et al.
2002; Nobuhara et al. 1999; Ohno et al.
2002a). In contrast, synthesized STs (ST-1,
ST-2, ST-3, ST-4, and ST-5) increased the
proliferation of human MCF-7 cells at 10–6
M (Ohyama et al. 2001), a concentration
considerably lower than those used in the
studies by Nobuhara et al. (1999) and Ohno
et al. (2002a), suggesting that these chemicals
may bind human ER-α at a lower concentra-
tion. However, the estrogenic activity of STs
observed by Ohyama et al. (2001) was
extremely weak—1/68,000—which was less
than that of 17β-estradiol. More recently, ST-
1, ST-3, and ST-4 [0–1,000 µg/kg body
weight (bw) per day] were reported to
markedly decrease the relative weight of testes
in the offspring of Sprague-Dawley rats; ST-3
and ST-4, but not ST-1, decreased the relative
weight of brain, whereas ST-1 and ST-4 sig-
nificantly decreased Sertoli cell counts and
plasma luteinizing hormone levels (Ohyama
et al. 2007). Conversely, these two STs
increased plasma testosterone levels and short-
ened the anogenital distance in the offspring.
In addition, ST-2, ST-3, ST-4, and ST-5 had
binding afﬁnities for androgen receptor (Satoh
et al. 2001). Thus, although the reason for the
above-mentioned conﬂicting reports has not
been resolved, some STs may have potential
toxicity as endocrine disruptors.
UDP-glucuronosyltransferase (UGT) is
involved in the conjugation of xenobiotics as
well as endogenous hormones such as thyroxin
(T4) and steroids (Emi et al. 1995; Maglich
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BACKGROUND: Styrene trimers (STs) are polystyrene-container–eluted materials that are sometimes
detected in packaged foods. Although the possible endocrine-disrupting effects of STs, such as estro-
genic activities, have been reported, their potential thyroid toxicity, such as that caused by the related
endocrine disruptor 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), has not been studied in detail. 
OBJECTIVE: Using wild-type and aryl hydrocarbon receptor (Ahr)–null mice, we investigated
whether 2,4,6-triphenyl-1-hexene (ST-1), an isomer of STs, inﬂuences thyroxin (T4) levels in the
same manner as TCDD, which induces UDP-glucuronosyltransferase (UGT) via the AhR, result-
ing in a decrease in T4 levels in the plasma of mice. 
METHODS: Both wild-type and Ahr-null mice (ﬁve mice per group) were treated for 4 days by gavage
with ST-1 (0, 32, or 64 µmol/kg). 
RESULTS: High-dose (64 µmol/kg) ST-1 decreased the expression of AhR, cytochrome P450 (CYP)
1A1/2, UGT1A1/A6, and CYP2B10 mRNAs and the enzyme activity for CYP1A and UGT1A
only in the wild-type mice. This dose decreased AhR DNA binding, but paradoxically increased
AhR translocation to the nucleus. In contrast, a high dose of ST-1 increased T4 levels in the plasma
in wild-type mice but did not inﬂuence T4 levels in AhR-null mice. 
CONCLUSIONS: Although ST-1 treatment might cause an increase in AhR levels in the nucleus by
inhibiting AhR export, this chemical down-regulated AhR mRNA, thus leading to down-regulation
of AhR target genes and an increase in plasma T4 levels.
KEY WORDS: aryl hydrocarbon receptor, cytochrome P450 1A, styrene trimer, thyroid hormone,
UDP-glucuronosyltransferase. Environ Health Perspect 116:740–745 (2008). doi:10.1289/ehp.10724
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UGT2, exist (Burchell and Coughtrie 1997;
Mackenzie et al. 1997). In the UGT1A family,
UGT1A1 and UGT1A6 catalyze the conjuga-
tion of bilirubin and phenols as well as T4
(Emi et al. 1995; Nishimura et al. 2005).
UGT1A1 is regulated not only by the aryl
hydrocarbon receptor (AhR) but also by the
constitutive androstane receptor (CAR)
(Sugatani et al. 2001, 2004; Zhou et al. 2005),
whereas UGT1A6 seems to be regulated only
by AhR, because a single dose of 10 µg/kg
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
to pregnant mice induced this isozyme only in
AhR (+/–) offspring, not in AhR-null mice
(Nishimura et al. 2005). This resulted in a
marked reduction of total and free T4 levels in
the serum of AhR (+/–) mice. In addition,
0.003–30 µg/kg TCDD dose-dependently
increased UGT activity for T4, but it reduced
T4 levels in the serum of rats (Craft et al.
2002). Thus, the disruption of thyroid
hormone homeostasis by TCDD may be
mediated via AhR. Interestingly, TCDD dose-
dependently decreased plasma T4 levels not
only in animals but also in humans (Turyk
et al. 2007), although in the latter case, the
exposure was evaluated as a dioxin-like toxic
equivalent. Other chemicals, such as 3-methyl-
cholanthrene (3MC) and polychlorinated
biphenyl (PCB) are also known to increase
UGT activity for T4 (Hood and Klaassen
2000) and to reduce serum T4, suggesting that
UGT activity is an important factor in the
homeostasis of T4 levels.
STs structurally have three aromatic rings,
suggesting that these chemicals may be AhR
agonists and influence UGT activity for T4
similar to the action of TCDD, PCB, or 3MC,
which also have two or three aromatic rings. To
investigate whether STs affect T4 levels via
AhR-mediated UGT genes, we selected ST-1
(CAS no. 18964-53-9; Figure 1) for this study
because of its relatively high toxicity: This iso-
mer has higher proliferation activity for MCF-7
and higher afﬁnity for human ER-α than do
the other isomers (Ohyama et al. 2007). We
investigated whether ST-1 alters T4 levels by
inducing expression of drug-metabolizing
enzymes via AhR similar to that observed with
the AhR ligand TCDD. Contrary to expecta-
tions, ST-1 down-regulated AhR in a manner
distinct from that of the positive activator
TCDD.
Materials and Methods
Chemicals. We obtained ST-1 (98.9%) from
Hayashi Pure Chemical Industry (Osaka,
Japan); resoruﬁn, 7-ethoxyresoruﬁn, 1-naph-
thol, UDP-glucuronic acid, and 3-methyl
cholanthrene from Sigma Chemical Co. (St.
Louis, MO, USA); anti-AhR goat IgG and
biotinlated anti-goat IgG from Santa Cruz
Biotechnology Inc. (Santa Cruz, CA, USA);
and phosphatase-conjugated streptavidin
from Jackson Immuno Research Laboratories
Inc. (West Grove, PA, USA).
Animals. We conducted this animal study
according to the Guidelines for Animal
Experiments of the Nagoya University Animal
Center. The animals were treated humanely
and with regard for alleviation of suffering. To
clarify the involvement of AhR in the effect of
ST-1 on the plasma T4 levels, we used two
genotyped mice, wild-type and AhR-null mice,
in this experiment. All mice were housed in
cages in a clean room under controlled temper-
ature (23–25°C), relative humidity (57–60%),
and light (12/12-hr light/dark cycle). For
breeding and for experimental use of wild-type
mice, we purchased 8-week-old male mice
(C57BL/6N) from CLEA Japan Inc. (Tokyo,
Japan). Ahr-null mice, described previously by
Fernandez-Salguero et al. (1995), were trans-
ferred to Nagoya University. Ahr-hetero [Ahr
(+/–)] female mice were mated with Ahr-null
male mice, and the Ahr gene and null allele of
their offspring were genotyped. Twelve-week-
old wild-type male mice [Ahr (+/+)] and
Ahr-null male mice [Ahr (–/–)] were used
throughout the experiments. 
We treated all mice [eight wild-type mice
in the measurement of free triiodothyronine
(T3) and thyroid-stimulating hormone (TSH);
five mice of each genotyped group for the
other markers] with 0, 32, and 64 µmol/kg bw
ST-1 by gavage for 4 consecutive days.
Because no LD50 (dose lethal to 50%) has
been identified for STs , we determined the
dose of ST-1 used in this experiment from the
LD50 of styrene (3 mmol/kg) [Registry of
Cytotoxicity Data (ZEBET) 7.1, National
Institutes of Health, Berlin, Germany]. We
used 32 µg/kg (low-dose group), which is
about 1/100th of the LD50 of styrene, and
64 µg/kg (high-dose group), which is 2-fold
that of the low-dose group. To determine
the exact induction of AhR target genes, we
used 3MC as an AhR activator. Twelve-week-
old wild-type male mice were given 3MC
(20 mg/kg bw) by gavage for 4 consecutive
days. All animals were killed by decapitation
16 hr after the last dose, and the blood and
livers were quickly removed. A part of the liver
was kept for later isolation of total RNA. The
remaining liver and the plasma were stored at
–80°C until use.
Real-time quantitative polymerase chain
reaction (PCR) analysis. We monitored the
mRNA levels of AhR, CYP1A1/2, UGT1A1/A6,
CAR, and CAR-mediated gene CYP2B10 on an
ABI PRISM 7000 Sequence Detection system
(Applied Biosystems, Foster City, CA, USA).
Total RNA was extracted from the liver of mice
exposed to ST-1, vehicle, or 3MC using the
RNeasy Protect Mini Kit (Qiagen, Tokyo,
Japan). Complementary DNA (cDNA) was
synthesized from 1 µg total RNA using
oligo(dT)20 primer. RNA quantity and quality
were determined using the Gene Quant 2
RNA/DNA calculator (Pharmacia Biotech,
Framingham, MA, USA). We designed the
primers using Primer Express 1.0 software
(Applied Biosystems) (Table 1). The PCR
mixture (25 µL) contained 1× SYBR Green
Master Mix (Applied Biosystems), 0.1 µM of
forward primer, and cDNA diluted by Tris-
EDTA buffer, including 1 mg/mL transfer-
RNA (the experiment was repeated for each
primer). PCR ampliﬁcation was as follows: an
initial step for 2 min at 50°C, then 10 min at
95°C, followed by 50 cycles at 95°C for
15 sec and 60°C for 1 min. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used
as a housekeeping gene for data analysis. We
normalized all mRNA expression levels to
GAPDH mRNA in the same preparation.
Preparation of microsomes and cytosols.
Liver was homogenized with a 3-fold volume of
10 mM phosphate buffer (pH 7.4) containing
0.25 M sucrose. Supernatants were centrifuged
at 10,000 × g for 10 min, and then further cen-
trifuged at 105,000 × g for 60 min. The pellet
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Figure 1. Chemical structure of ST-1.
CH2
C
H2
C
2,4,6-Triphenyl-1-hexene (ST-1)
C
H2
CH
H2
C
Table 1. Primers used for real-time PCR to quantify mRNA expression of AhR-related gene.
Gene (GenBank accession number)a Forward primer (5´ to 3´) Reverse primer (5´ to 3´)
AhR (NM 013464) CTGTGTCCTTCAAGC CCGCACTTGCTCACGGA
CYP1A1 (NM009992) CGTTCCAGCTTCCTGTCCTGA AGGACATTTGAGAAGGGCCA
CYP1A2 (NM009993) CCATGTGCTTTGGGAAGAACTT GTCCTTGCTGTTATTCACGATGTT
UGT1A1 (AF093878) TGAACTTCCTACAGCGACTGAAGA GGGAATAAACCACTCTGCACATAA
UGT1A6 (D87867) CCTTTGGAAACAACCACTTTCTTC CGACAATCATGTTGTTCCTGTACTC
CAR (AF009327) CAGGGTCCAGTACGAGTTTTTG AGGCTCCTGGAGATGCAGTC
CYP2B10 (AF128849) CCAACCAGCACACGGACTT CGGTGCCAGCAAAGAAGAG
GAPDH (BC096440) AGAACATCATCCCTGCATCCA CCGTTCAGCTCTGGGATGAC
aGenBank data are available from the National Center for Biotechnology Information (2008). (microsomal fraction) was resuspended in the
same buffer, and the supernatant (cytosol frac-
tion) was stored at –80°C until use.
Preparation of nuclear fraction. We
extracted the nuclear fraction from frozen
liver of each mouse using a protein extraction
reagent T-PER (Pierce Biotechnology,
Rockford, IL, USA).
Analysis of protein concentrations. We
measured protein concentrations of the
homogenate, cytosol, and nuclear fractions
using Bio-Rad Protein Assay (Bio-Rad,
Tokyo, Japan).
Ethoxyresorufin O-deethylase (EROD)
activity. We measured EROD activity in liver
microsomes using 7-ethoxyresoruﬁn as a sub-
strate according to the method of Hanioka
et al. (2000). Liver microsomes (120 µg pro-
tein) were mixed in a reaction mixture of
50 mM phosphate buffer (pH 7.4) and
0.1 mM 7-ethoxyresoruﬁn. The reaction was
started by the addition of nicotinamide ade-
nine dinucleotide phosphate (NADPH)
(10 mM) in a ﬁnal volume of 500 µL. After
incubation at 25°C for 5 min, the reaction was
stopped by adding 500 µL ice-cold methanol,
and the reaction vial was cooled on ice for
15 min, followed by the centrifugation at
6,000 × g for 20 min. The supernatant was ﬁl-
tered with a disposable disk filter (HPLC-
DISK-3 0.2 µm; Kanto Kagaku, Tokyo,
Japan). Aliquots (10 µL) were subjected to
HPLC using a Hitachi L-6000 equipped with
an F-1080 fluorescence detector (Hitachi,
Tokyo, Japan), an AS-2000 auto sampler, a
D-2500 chromatointegrator (Hitachi), and an
ODS-80A column (GL Sciences, Tokyo,
Japan). As a mobile phase, 20 mM phosphate
buffer (pH 6.8):methanol:acetonitrile
(52:45:3, vol/vol/vol) was used at a ﬂow rate
of 1.0 mL/min. The excitation and emission
wavelengths were fixed at 535 nm and
585 nm, respectively.
UGT activity. We measured UGT activity
in liver microsomes using 1-naphthol as a sub-
strate according to the method of Yokota et al.
(2002). Liver microsomes (100 µg protein)
were treated with 0.25% Triton-X at 37°C for
5 min, followed by adding the reaction mix-
ture [40 mM Tris-HCl buffer (pH 7.4),
0.8 mM MgCl2, and 0.2 mM 1-naphthol].
The reaction was started by adding UDP-
glucuronic acid (1.8 mM) in a final volume
of 500 µL. After the vials were incubated at
37°C for 10 min, the reactions were stopped
by the addition of 500 µL ice-cold acetoni-
trile, and the reaction vial was cooled on ice
for 15 min. The mixture was then centrifuged
at 10,000 × g for 5 min, and the supernatant
was filtered with a disposable disk filter
(HPLC-DISK-3, 0.2 µm; Kanto Kagaku).
HPLC was performed using an aliquot (10 µL)
of supernatant and a Hitachi L-6000 equipped
with an L-4200 UV-VIS detector, an AS-2000
auto sampler, a D-2500 chromatointegrator
(Hitachi), and a GH-C18 column (Hitachi).
As a mobile phase, acetonitrile/distilled
water/acetic acid (35:65:0.1, vol/vol/vol) was
used at a ﬂow rate of 1.0 mL/min. The wave-
lengths were ﬁxed at 221.5 nm. 
Determination of AhR protein levels by
Western blotting. The nuclear fraction (25 µg
protein) and the cytosolic fraction (25 µg pro-
tein) were separated by 10% SDS-PAGE and
transferred to nitrocellulose membranes (Bio-
Rad). After blocking with 3% skim milk, each
membrane was incubated with anti-AhR anti-
body (1:200) for 1 hr. The membrane was
washed with Tris-buffered saline (TBS,
pH 7.4) and TBS containing 0.1% Tween-20
(TBST), and incubated with the biotinlated
anti-goat IgG antibody (1:5,000) for 1 hr.
After washing the membrane with TBS and
TBST, the membrane was incubated with
alkaline phosphatase-conjugated streptavidin
(1:5,000) for 1 hr. The membrane was washed
with TBST and TBS, and specific immune
complexes were detected with 1-Step NBT/
BCIP (Pierce Biotechnology). Each band was
quantified using densitometry with Lane &
Spot Analyzer, version 5.0 (ATTO, Tokyo,
Japan), and the mean strength of the control
group was assigned a value of 1.0.
Electrophoretic mobility shift assay. A dou-
ble-stranded xenobiotic response element (XRE)
fragment corresponding to the consensus XRE
of CYP1A1 promoter (forward, 5´-GATCTG-
GCTCTTCTCACGCAACTCCG-3´; reverse,
5´-GATCCGGAGTTGCGTGAGAA-
GAGCCA-3´) was labeled with biotin using
the Biotin-Labeling Kit (Pierce Biotechnology)
according to the method of Denison et al.
(1988). Nuclear extract (5 µg) was then incu-
bated with biotin-labeled DNA at room tem-
perature for 20 min in 1× gel shift buffer
supplemented with poly(dI-dC; 0.5 µg/µL).
The reaction samples were resolved on non-
denaturing electrophoresis (4% acrylamide) and
transferred to a positively charged nylon mem-
brane (Roche Diagnostics, Mannheim,
Germany). AhR–XRE complex was detected
Yanagiba et al.
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Figure 2. Real-time quantitative PCR analyses of
liver CYP1A1 (A) and CYP1A2 (B) mRNA and micro-
somal CYP1A enzyme activity (EROD; C) in wild-type
and AhR-null control ST-1–exposed mice. Values
represent mean ± SD (n = 5). 
*Significantly different from the corresponding control
(p < 0.05). 
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Figure 3. Real-time quantitative PCR analyses of liver
UGT1A1 (A) and UGT1A6 (B) mRNA levels, and
microsomal UGT enzyme activity (C) in wild-type and
AhR-null control and ST-1–exposed mice. Values
represent mean ± SD (n= 5). 
*Significantly different from the corresponding control
(p < 0.05). 
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Figure 4. Effects of ST-1 treatments on expression
of CAR (A) and CYP2B10 (B) mRNA levels in the liv-
ers of wild-type and AhR-null mice. Values repre-
sent mean ± SD (n = 5). 
*Significantly different from the corresponding control
(p < 0.05). 
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Treatmentwith a Chemiluminescent Nucleic Acid
Detection Module (Pierce Biotechnology) and
visualized using a Lumi Vision PRO HS II
(Aisin Seiki, Aichi, Japan). Each band was
quantiﬁed using densitometry with the Lane &
Spot Analyzer, and the mean strength of the
control group was assigned a value of 1.0.
Measurement of thyroid hormone concen-
tration. Total T4 concentration in plasma was
measured by electrochemiluminescence
immunoassay (SRL Inc., Tokyo, Japan). The
amounts of free T4 in plasma were measured
using Amerlex-MAb FT4 kits (Trinity Biotech,
Bray, Ireland). The levels of free T3 in plasma
were measured using EIA FREE T3 (T193;
Leinco Technologies Inc., St. Louis, MO,
USA). Because no kit was available for mouse
TSH, we measured the amount of TSH in
plasma using a radioimmunoassay kit for
rat TSH [National Institute of Diabetes,
Digestive, and Kidney Diseases (NIDDK)
National Hormone and Peptide Program,
National Institutes of Health, Bethesda, MD,
USA]. In the preliminary experiment, we con-
ﬁrmed the possibility of the kit’s use for analyz-
ing mouse plasma TSH levels. The antiserum
used was anti-rat TSH-S-6 (AFP329691Rb),
and the hormone for iodination was rat TSH-
I-9 (AFP11542B). Results are expressed in
terms of NIDDK rat TSH-RP-3 (AFP5512B)
so that we could determine the values relative
to those of rats, although the results are not
absolute values for mice. The intraassay and
interassay coefﬁcients of variation were 3.4%
and 5.2%, respectively.
Statistical analysis. We performed statisti-
cal analysis using two-way analysis of variance
(ANOVA), followed by Dunnett’s test using
JMP, version 4.0 (SAS Institute Inc., Cary,
NC, USA). When only wild-type mice were
used, Dunnett’s test was employed after one-
way ANOVA. p-Values < 0.05 were consid-
ered statistically signiﬁcant.
Results
ST-1 effects on AhR- and CAR-mediated genes.
ST-1 treatment did not inﬂuence the body or
organ weights of wild-type and AhR-null mice
(data not shown). To determine the up- or
down-regulation of AhR by ST-1, we meas-
ured CYP1A1 and CYP1A2 genes and their
activity. High-dose (64 µmol/kg) ST-1 signiﬁ-
cantly decreased the expressions of CYP1A1
and CYP1A2 mRNAs in the livers of wild-type
mice but did not inﬂuence those in Ahr-null
mice (Figure 2A,B). Similarly, high and low
(32 µmol/kg) dosages of ST-1 significantly
decreased CYP1A1 activity, as measured by the
rate of dealkylation of 7-ethoxyresoruﬁn, only
in the liver microsomes from wild-type mice
(Figure 2C). High-dose ST-1 also signiﬁcantly
decreased the expressions of UGT1A1 and
UGT1A6 mRNAs only in the liver from wild-
type mice (Figure 3A,B). Similarly, high- and
low-dose ST-1 significantly decreased UGT
activity for 1-naphthol as a substrate in liver
microsomes from wild-type mice but not in
Ahr-null mice (Figure 3C). High- and low-
dose ST-1 also significantly decreased the
expression of CYP2B10 mRNA in the liver
from wild-type mice, but not in that from Ahr-
null mice. ST-1 did not alter CAR mRNA
(Figure 4).
ST-1 effects on expression of AhR mRNA
and protein. Because ST-1 treatment signiﬁ-
cantly decreased the CYP1A1 and CYP1A2
mRNA levels only in wild-type mouse liver,
we measured the expressions of AhR mRNA
and protein in wild-type mouse liver. As a
positive marker for the induction of AhR, we
also used the livers of wild-type mice treated
with 3MC. 3MC significantly induced AhR
mRNA in the liver and the protein in the
nuclear fraction (Figure 5A,C). In contrast,
ST-1 treatment significantly decreased the
expression of AhR mRNA. ST-1 treatments
unexpectedly increased AhR protein in the
hepatic nucleus. 3MC and ST-1 did not
inﬂuence the AhR protein levels in the cytosol
fractions (Figure 5B).
Electrophoretic mobility shift assay.
Because ST-1 treatment signiﬁcantly decreased
the AhR, CYP1A1, and CYP1A2 mRNA levels
but AhR protein accumulated in hepatic nuclei
from wild-type mice, we analyzed expression
of AhR binding to XRE by electrophoretic
mobility shift assay. As a positive marker, we
also used nuclear protein of mice treated with
3MC. AhR–XRE complexes were detected in
all nuclear samples. 3MC significantly
increased the expression of AhR–XRE com-
plexes, but high-dose ST-1 decreased the
expression compared with that of the hepatic
nucleus of controls (Figure 6).
ST-1 effects on thyroid hormone. Because
ST-1 treatment significantly decreased the
expressions of UGT1A1 and UGT1A6 mRNA
as well as activity, we measured T4 levels in the
plasma in wild-type and Ahr-null mice. We
detected no differences in the plasma total T4
levels between control groups of wild-type and
Ahr-null mice (Table 2). High-dose ST-1
increased the total T4 level in the plasma from
wild-type mice but not from Ahr-null mice.
Therefore, we measured plasma free T4, free
T3, and TSH levels only in wild-type mice.
High-dose ST-1 also increased free T4 levels
but did not inﬂuence T3 and TSH levels.
Discussion
The present study revealed that ST-1 exposure
decreased expression of the CYP1A1, CYP1A2,
UGT1A1, and UGT1A6 genes via suppression
of the AhR gene in mice, as shown by the
decrease of mRNAs and activity in the wild-
type mice, but not in Ahr-null mice. On the
contrary, AhR protein accumulated in the
nucleus but AhR-XRE complex decreased in
the nucleus of ST-1–treated mouse liver.
Styrene trimer may affect thyroid hormone via AhR
Environmental Health Perspectives • VOLUME 116 | NUMBER 6 | June 2008 743
Figure 5. Real-time quantitative PCR analysis of
AhR mRNA in the liver (A) and immunoblot analysis
AhR protein in the cytosol (B) and nuclear (C) frac-
tions of control, 3MC-, and ST-1–exposed wild-type
mice. Liver samples from 3MC-treated mice were
used to determine the induction of AhR and AhR-
target genes. Values represent mean ± SD (n= 5). 
*Signiﬁcantly different from the corresponding control by
Dunnett’s test (p < 0.05).
2.5
2.0
1.5
1.0
0.5
0.0
*
*
*
A
h
R
/
G
A
P
D
H
m
R
N
A
R
e
l
a
t
i
v
e
 
i
n
t
e
n
s
i
t
y
A
h
R
A
B
C
*
*
2.5
2.0
1.5
1.0
0.5
0.0
2.5
2.0
1.5
1.0
0.5
0.0
R
e
l
a
t
i
v
e
 
i
n
t
e
n
s
i
t
y
A
h
R
3MC
Control
ST-1 (32 μmoL/kg)
ST-1 (64 μmoL/kg)
Cytosol fraction
Nuclear fraction
Treatment
Treatment
Treatment
Figure 6. Electrophoresis mobility shift assay of
AhR–XRE complex in liver nuclear fraction of con-
trol, 3MC-treated, and ST-1–treated wild-type
mice (A) and quantiﬁcation of the assay by densito-
metric analysis (B), with the mean strength of the
control group assigned a value of 1.0. Values repre-
sent the mean ± SD (n = 5). 
*Significantly different from the correspondng control by
Dunnett’s test (p < 0.05).
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TreatmentThese ﬁndings are considerably different from
the transcriptional activation of AhR by
TCDD, PCB, or 3MC, which significantly
induce the drug-metabolizing enzymes
described above via AhR and increase AhR
protein and AhR-XRE complex in the nucleus
(Gonzalez 1998; Shimizu et al. 2000).
Although it is unclear why the expression of
AhR protein in the nucleus stained by anti-
AhR was increased by ST-1 treatment, high-
dose ST-1 increased the plasma T4 level only
in the wild-type mice, which may have been
due in part to the AhR down-regulation by
ST-1 and consequent decrease in UGT1A
expression. To our knowledge, this is the ﬁrst
study to demonstrate that a relatively high
dose of ST-1 induced an increase in T4 plasma
levels in mice.
T4 is conjugated with UDP-glucuronic
acid by the catalytic action of UGT1A1 and
UGT1A6, which have XRE in the promoter
region and are activated by AhR agonists such
as TCDD, PCB, and 3MC in Wistar rats (Emi
et al. 1995). In fact, Nishimura et al. (2005)
reported that TCDD markedly reduced serum
total T4 and free T4 levels only in AhR hetero-
zygous mice by inducing UGT1A6 mRNA
and thereby increased biliary excretion of the
T4 glucuronide. Unfortunately, in their study,
they did not measure whether TCDD also
induced UGT1A1 only in the liver. On the
other hand, 3MC and phenobarbital, which
are AhR and CAR agonists, respectively,
induced UGT1A1 mRNA and protein (Emi
et al. 1996; Mackenzie et al. 1997; Sugatani
et al. 2001, 2004). Because CYP2B10 is a CAR
target gene (Maglich et al. 2004; Wei et al.
2000), the decreased level of CYP2B10 mRNA
by ST-1 treatment suggests that this com-
pound might also down-regulate CAR and
participate in the decreased expression of
UGT1A1, although the expression of CAR
mRNA did not decrease signiﬁcantly. Taken
together, CAR may also be involved, in part, in
the decrease in UGT1A1 by ST-1 treatment.
However, we cannot rule out the involvement
of CAR in the expression of UGT1A6 in the
present study. Thus, ST-1 treatment down-
regulated UGT1A1 and UGT1A6 genes,
which might result in increased total T4 and
free T4 levels in serum because of the
decrease in the conjugation of T4 with UDP-
glucuronide and a decrease in the excretion of
T4 to the bile duct. The inﬂuence of ST-1 on
the plasma total T4 and free T4 levels was con-
trary to that of TCDD or 3MC. In contrast to
T4 levels, plasma T3 levels were not inﬂuenced
by ST-1 treatment. 3MC or PCB treatment
for 7 days (Hood and Klaassen 2000; Vansell
and Klaassen 2001) and a single oral adminis-
tration of TCDD (Nishimura et al., 2002) also
did not influence plasma T3 levels in rats,
although these chemicals decreased T4 levels in
plasma, suggesting that T3 levels would not be
inﬂuenced by such chemicals.
Although relatively short-term exposure
(7 days) to 3MC and PCB decreased T4 levels
in plasma in rats, they did not inﬂuence plasma
TSH levels (Hood and Klaassen 2000). In con-
trast, long-term exposure (8 weeks) to one of
the catechins involved in green tea (polyphe-
none-60) decreased T4 levels and, conversely,
increased TSH levels (Satoh et al. 2002). In our
experiment, ST-1 treatment did not decrease
TSH levels in the plasma of wild-type mice,
although it did increase T4 levels. It is unknown
whether the unchanged TSH is due to the
short-term exposure to ST-1. Because the effect
of ST-1 treatment on plasma T4 levels was
investigated only from the viewpoint of T4 glu-
curonidation, the effects on thyroid hormone
biosynthesis, thyroid hormone signaling in thy-
roid, and TSH biosynthesis and release in
hypothalamus and pituitary were not investi-
gated. Further study is warranted to determine
whether ST-1 treatment inﬂuences this process.
Of course, the effect of long-term exposure to
ST-1 on thyroid hormone systems also has to
be determined. In fact, certain catechins
involved in green tea—which down-regulate
the AhR-related gene CYP1A1 and also might
be suspected to down-regulate UGT1A—
caused histopathologic changes in thyroid
(Goodin et al. 2006; Sakamoto et al. 2001).
A model for the nucleo-cytoplasmic shut-
tling of AhR has been reported (Ikuta et al.
2000; Pollenz and Barbour 2000). First, some
ligands bind to AhR associated with heat-shock
protein 90 (HSP90), which translocates into
the nucleus. In the nucleus, AhR and AhR
nuclear translocator (Arnt) dimerize to form the
AhR–Arnt heterodimer, which is competent to
bind XRE in the promoter of specific genes
such as CYP1A1. After transactivating the tar-
get gene, the heterodimer is dissociated by the
action of the nuclear export signal (NES).
Chromosome region maintenance 1 protein
(CRM1), which participates in nuclear protein
export as a receptor of NES, accesses and recog-
nizes the NES. Then, AhR bound to CRM1 is
exported from the nucleus to the cytoplasm. In
general, the AhR agonist induces AhR-mediated
genes such as CYP1A1, but the antagonist lep-
tomycin B was found to inhibit gene induction
(Ikuta et al. 2000; Pollenz and Barbour 2000).
In the latter case, AhR protein recognized by
anti-AhR accumulated in the nucleus. Because
leptomycin B inhibited AhR export, the inac-
tive AhR remained in the nucleus and therefore
down-regulated transcription of AhR-mediated
genes (Ikuta et al. 2000; Pollenz and Barbour
2000). In the present study, ST-1 treatment
increased AhR recognized by anti-AhR. Thus,
ST-1 might inhibit AhR export, resulting in
accumulation of the inactive AhR in the
nucleus, similar to that of leptomycin B. Taken
together, ST-1 might down-regulate the AhR-
mediated genes by both down-regulation of
AhR gene and the inhibition of export of
inactive AhR from the nucleus into cytosol.
Conclusion
The high dose of ST-1 used in this study sig-
niﬁcantly down-regulated AhR and the medi-
ated genes such as UGT1A1/A6, which may
have resulted, in part, in the increase in
plasma T4 levels. Although this dose is con-
siderably higher than levels of ST-1 in the
general environment, this new information is
very valuable for the risk assessment of STs.
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